Monthly Archives: June 2020

Top Criminal Defense Attorney Saul Bienenfeld Highlights Key Steps When Accused Of A Sex Crime Offense – New York

Leading criminal defense attorney Saul Bienenfeld owner of Bienenfeld Law in New York, NY outlines what to do if accused of a sex crime offense. For more information please visit https://bienenfeldlaw.com

New York, NY, United States – June 29, 2020 /MM-REB/ —

In a recent interview, seasoned criminal attorney Saul Bienenfeld owner of Bienenfeld Law in New York, NY explained what to do if accused of a sex crime offense.

For more information please visit https://bienenfeldlaw.com

When asked to comment, Bienenfeld said, “Many are unsure where to turn when facing a sex crime charge. A seasoned attorney can build a strong case against the prosecutor and accuser, which could help defend you against being found guilty.”

Sex crime charges are very serious in New York and could have severe repercussions for anyone found guilty of such an offense.

“Sex crimes are more often than not classified as felony offenses and are taken extremely serious by police and the courts. Some sex crimes include child sexual abuse, statutory rape, possession of child pornography, and indecent exposure,” he explained.

“Being found guilty could lead to mandatory prison time or sex offender registration, or both. This makes it even more important for anyone accused of a sex crime offense to know exactly what to do,” he said.

Many people – particularly those who have been falsely accused of a sex crime – tend to make the mistake of trying to resolve their case themselves, instead of seeking outside help. After all, the citizen who is inexperienced with the criminal justice system may very well assume that their actual innocence will be enough, when the police and prosecutor look at that case carefully enough, to result in the dropping of the charges. Sadly, this is almost never true.

“The best thing you can do is to contact a seasoned attorney. In other words, don’t try to take matters into your own hands by speaking with police officers or with anyone involved in the case. This will often make things worse and will, in fact, often strengthen the State’s case against you,” Bienenfeld said.

An experienced criminal defense attorney will be able to put together a strong defense that pokes holes in the other side’s argument.

“Let’s say that you’ve been falsely accused of committing a sex crime. In my experience, there are many reasons that motivate people to claim that a sex crime happened when it didn’t. These could include revenge or that the accuser is attempting to hide an affair – or it could even be a case of mistaken identity where alcohol or drug use or abuse is involved,” he said.

Bienenfeld said that whatever the case, a criminal defense attorney will cut through the noise and build the strongest case possible to help fight both the actual sex crime charges, and the stigma that has no place attaching to those who are falsely accused of such a crime.

Source: http://RecommendedExperts.biz

Contact Info:
Name: Saul Bienenfeld
Email: Send Email
Organization: Bienenfeld Law
Address: 450 7th Ave #1408, New York, NY 10123
Phone: (212) 363-7701
Website: https://bienenfeldlaw.com

Source: MM-REB

Release ID: 88966163

Atlas Real Estate Has Been Re-Branded as Atman Real Estate

In Addition to Focusing on Lead Generation for Realtors, Atman Real Estate is Also Launching a New Branch of Services Called Victorious PR

LOS ANGELES, CA / ACCESSWIRE / June 29, 2020 / Chief Executive Officer Victoria Kennedy is pleased to announce that her company Atlas Real Estate has been re-branded and is now known as Atman Real Estate.

To learn more about Atman Real Estate and the services that Kennedy and her team offer, please check out https://www.atmanrealestate.com/.

As Kennedy noted, the newly re-branded Atman Real Estate will no longer focus solely on lead generation for Realtors. Kennedy has added a new branch of publicity called Victorious PR for the agents she works with; Realtors who visit https://www.victoriouspr.com and set up a phone call will learn how to get even more exposure for themselves and their business.

"At Atman Real Estate, we connect Realtors with motivated buyers and sellers to get you more appointments with qualified leads," Kennedy said, adding that she and her team guarantee that the Realtors they work with will get a set amount of exclusive leads a month coming out of their personal Facebook page to brand them as the agent.

"We will call, text, and email every lead for you and connect you with serious buyers and sellers. We will continue to nurture each lead for up to 6 months so whenever they are ready to buy or sell, you are the agent they call."

Realtors who have worked with Kennedy will not be surprised that she has added PR to her already impressive list of services. Since Kennedy first launched her company, she has earned a well-deserved reputation for being able to get her Realtor clients in the media and establish them as the authority in their communities.

Although Kennedy enjoys helping as many Realtors as possible to get more publicity and increase their business, she stressed that her new Victorious PR services are for all business owners, entrepreneurs and marketers in any and all stages of growth.

"This program works in all markets, be it service-based, product-based, info-based, or anything in between. We know how to get you in the proper publications that are specific to you and your industry," Kennedy said.

About Atman Real Estate:

Atman Real Estate is a PR and Marketing agency that is committed to providing more publicity and closings for Real Estate professionals. They are committed to getting their agents in the press as the authority in their communities. Find out more at: https://www.atmanrealestate.com/.

Contact:

Victoria Kennedy
support@victoriakennedyofficial.com
7029358906

SOURCE: Atman Real Estate

ReleaseID: 595599

A Hero in the Pandemic Who Lives with Autism Fed in Two Months 105 Disabled Families and Mailed over $8200 in Grocery Cards

Disabled communities in Massachusetts affected by Covid-19 cannot wait in food bank lines.

WEST ROXBURY, MA / ACCESSWIRE / June 29, 2020 / Esteban Barriga, 24 who attends the Barry Price Center in Newton and is the Co-Founder of Autism Geniuses of the World, AGW, with the support of his mother Maribel Rueda, launched a supermarket card donation campaign called "AGW Food Drive" to help feed Massachusetts disabled communities affected by COVID-19, who could not stand in a food bank line,

"That's why we decided to start collecting $25 grocery cards from local supermarkets to mail to families who have a disabled person at home," Esteban said while stressing that many of them need a special diet of fruits, vegetables, and proteins that they must buy at the market.

Families from all around Massachusetts received $25, $50, or $100 Stop & Shop grocery cards that were personally mailed by Esteban with a note, 46 went to families referred by the COVID-19 Information Center, eight to the Mozart Public School of Boston, coordinated by nurse Lucy, 21 to the Department of Public Health in Tewksbury, coordinated by Maribel Goglas, 30 to local food banks and community outreach referrals.

Stop & Shop cards, Start Market, Market Basket, or other local supermarket cards were mailed to Esteban's home address; Individuals donated via a Facebook fundraiser page, Cash App account and Sponsor donations.

Maribel Rueda says, "We were on a mission to feed as many disabled families as we could. In return, we received touching messages and videos from all the families who received the grocery cards."

"I just got Esteban's letter and card, to most people it may mean nothing but to me, it brightens up my day. We can now buy food for a month" wrote a mother from Cambridge Massachusetts.

Esteban and Maribel want to publicly acknowledge the community and sponsors who generously donated. The Puerto Rican Festival of Massachusetts and its board members, South Carolina Photographer, Marilyn Olivero of Paisa Photography, their family and friends. "Everyone's commitment to support Esteban's mission and help our disable communities made it a reality," said Maribel.

According to Johns Hopkins University, Massachusetts has over 108,667 COVID- 19 diagnosed cases and 8,060 deaths.

CONTACT:

Maribel Rueda
978-908-8900
maribel.rueda2020@outlook.com

SOURCE: Autism Geniuses of the World

ReleaseID: 595595

KL Investor Alert: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Kirkland Lake Gold Ltd. and Encourages Investors to Contact the Firm

NEW YORK, NY / ACCESSWIRE / June 29, 2020 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Kirkland Lake Gold Ltd. ("Kirkland" or "the Company") (NYSE:KL). Investors who purchased Kirkland securities between January 8, 2018 and November 25, 2019, both dates inclusive (the "Class Period"), are encouraged to obtain additional information and assist the investigation by visiting the firm's site: www.bgandg.com/kl.

The investigation concerns whether Kirkland and certain of its officers and/or directors have violated federal securities laws.

Throughout the Class Period, Defendants made materially false and/or misleading statements, and failed to disclose that: (1) Kirkland lacked adequate internal controls over financial reporting, especially as it relates to its projections of risks, reserve grade, and all-in sustaining costs; (2) as a result of the known, but undisclosed, impending acquisition of Detour, the Company's projections relating to its risks, reserve grade, and all-in sustaining costs were false and misleading; (3) the Company's financial statements and projections were not fairly presented in conformity with International Financial Reporting Standards ("IFRS"); (4) based on the foregoing, Defendants lacked a reasonable basis for their positive statements about the Company's business, operations, and prospects and/or lacked a reasonable basis and omitted material facts.

If you are aware of any facts relating to this investigation or purchased Kirkland shares, you can assist this investigation by visiting the firm's site: www.bgandg.com/kl. You can also contact Peretz Bronstein or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC: 212-697-6484.

Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm's expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein | Yael Hurwitz

212-697-6484 | info@bgandg.com

SOURCE: Bronstein, Gewirtz and Grossman, LLC

ReleaseID: 595634

NVS Investor Alert: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Novartis AG and Encourages Investors to Contact the Firm

NEW YORK, NY / ACCESSWIRE / June 29, 2020 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Novartis AG ("Novartis" or "the Company") (NYSE:NVS). Investors who purchased Novartis securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: www.bgandg.com/nvs.

The investigation concerns whether Novartis and the board of directors may have breached its fiduciary duties to shareholders.

On June 25, 2020, Novartis agreed to pay $225 million in criminal penalties and disgorge $112 million to settle bribery allegations. The U.S. Department of Justice and the Securities and Exchange Commission was investigating Novartis on claims that: (1) Novartis had bribed doctors and hospitals in Greece to prescribe "Novartis-branded pharmaceuticals"; (2) the Company had paid bribes in Vietnam to advance their business; and (3) Novartis falsified their financial records to conceal said activities. Following this news, Novartis stock dropped $2.50 per share on June 26, 2020.

If you are aware of any facts relating to this investigation, or purchased Novartis shares, you can assist this investigation by visiting the firm's site: www.bgandg.com/nvs. You can also contact Peretz Bronstein or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC: 212-697-6484.

Contact:

Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein | Yael Hurwitz
212-697-6484 | info@bgandg.com

SOURCE: Bronstein, Gewirtz & Grossman, LLC

ReleaseID: 595629

Cancer Immunotherapy Market To Reach USD 153.03 Billion By 2027 With CAGR 10.1%

An extensive study of the product application and services conducted by subject matter experts assessing the Cancer Immunotherapy Market will help product owners to make a wise decision.

New York, United States – June 29, 2020 /MarketersMedia/ —

The global cancer immunotherapy market is growing at a substantial pace owing to the growing acceptance and inclination of the patients towards the newly invented advanced treatments over the conventional ones. In order to substantialize the severe and chronic diseases like cancer, every year, the cancer research centers invest a handful of the amount in their R&D, which fuels up the market growth by a large margin.

The report highlights the impacts of the pandemic on the global Cancer Immunotherapy market, along with strategies and opportunities that one can benefit from, till 2020-2027. The research study includes the latest updates about the COVID-19 impact on the Cancer Immunotherapy sector. The outbreak has broadly influenced the global economic landscape. The report contains a complete breakdown of the current situation in the ever-evolving business sector and estimates the aftereffects of the outbreak on the overall economy.

For Better Understanding, Download Free Sample Copy of Cancer Immunotherapy Market Report @ https://www.reportsanddata.com/sample-enquiry-form/1550

The most influential and dominant participants of the global Cancer Immunotherapy industry are:
Medtronic, Ethicon (subsidiary of Johnson & Johnson), Cousin Biotech, EnteroMedics, Inc., and USGI Medical, Inc. VIVUS, Inc., Arena Pharmaceuticals, Inc., F. Hoffmann-La Roche Ltd., Novo Nordisk A/S, Allergan Plc.

The key factors responsible to drive the growth of cancer immunotherapy market include the technological advancements in treatment therapies, rise in incidence of cancer, increasing number of R&D for the treatment of cancer, and improving effectiveness of cancer immunotherapy for the treatment of a wide range of diseases such as lung cancer, breast cancer, skin cancer, and others. Besides, the rise in healthcare expenditure and healthcare insurance are expected to fuel the market growth during the analysis period.

Cancer Immunotherapy market Segments:
For the purpose of this report, Reports and Data have segmented into the global Cancer immunotherapy market on the basis of technology, application, end use, and region:
Technology Outlook (Revenue, USD Billion; 2017-2027)
• Monoclonal Antibodies
• Vaccines
• Checkpoint Inhibitors
• Cell Therapies
• Immune System Modulators
• Adoptive Cell Transfer
• Cytokines
• Others

Application Outlook (Revenue, USD Billion; 2017-2027)
• Head & Neck Cancer
• Blood Cancers
• Liver Cancer
• Lung Cancer
• Breast Cancer
• Prostate Cancer
• Melanoma
• Others

In addition to corporate strategies, the Cancer Immunotherapy market highlights important factors that act as market drivers or as market foreclosure factors, thus preventing the industry from moving forward. The report analyzes the key factors that influence the growth of the main market players and their presence in the market. Market share, production value, gross margin analysis, import and export scenario, consumption rate, and SWOT analysis are calculated for regions and countries.

Get Discount the Report @ https://www.reportsanddata.com/discount-enquiry-form/1550

Key Benefit of Cancer Immunotherapy Report:
– Meticulous analysis of the key aspects of the market that influence the trends and future of the Cancer Immunotherapy market. Also, the opportunities and threats in the market and weaknesses and strengths of the players operating in the market.
– Analysis of key player’s strategic initiatives and competitive developments, such as joint ventures, mergers, and new product launches in the market.
– Global, regional, country-level market size and their forecast.
– Identification of key market players and comprehensively analyze their market share and core skills, key products, detailed financial positions, and unique selling points.
– Expert discussions and their insights on market change, current and future outlook, and factors impacting vendor’s short term and long term strategies.

Further key findings from the report suggest
• The North America cancer immunotherapy market is anticipated to dominate the in the global market. The major driving factors for the growth of this market are rise in the adoption rate of immunotherapy over the conventional treatments due to lesser side effects and more survival efficiency and the diminishing lifestyle and increase in the rate of cancer affected patients.
• The monoclonal antibodies are expected to have the largest market share among the other segments. This is attributed to the fact that monoclonal antibodies have the largest class of drugs than other sectors of the cancer immunotherapy. The major market driver of the monoclonal antibodies market is the increasing prevalence of cancer in the forecast period.

Access Full Report Description, TOC, Table of Figure, Chart, Graph, etc. @ https://www.reportsanddata.com/report-detail/cancer-immunotherapy-market

About Us:
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyse consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market.

Contact Info:
Name: John Watson
Email: Send Email
Organization: Reports And Data
Address: 40 Wall St. 28th floor New York City, NY 10005 United States
Phone: +1-212-710-1370
Website: https://www.reportsanddata.com/

Source URL: https://marketersmedia.com/cancer-immunotherapy-market-to-reach-usd-15303-billion-by-2027-with-cagr-101/88966279

Source: MarketersMedia

Release ID: 88966279

Top Ways To Save Money On Auto Insurance

LOS ANGELES, CA / ACCESSWIRE / June 29, 2020 / Compare-autoinsurance.org (https://compare-autoinsurance.org/) has launched a new guide that presents the top methods used by drivers to get better car insurance rates.

Although expensive for some drivers, car insurance is a necessity for many. The penalties for driving without insurance can be severe and will reflect in the future policy premiums for many years after an uninsured driver gets caught.

In order to pay less on their car insurance, drivers can follow these tips:

Bundle multiple policies. Drivers can try to insure all vehicles from the household with the same insurance company in order to get a large discount. Moreover, drivers can try to insure the home with the same insurance company. Multi-policies and multi-car discounts can help policyholders save lots of money.
Check different discounts. Policyholders can check with their insurance agent if they are eligible for any discounts. Insurance companies are notorious for offering a great variety of discounts. The most popular discounts are the homeowner discount, good student discount, getting a married discount, and other various discounts that can appear in certain situations.
Keep a clean driving record. Insurance companies will reward drivers that keep a clean driving record with discounts that range from 10% to 20%. In order to qualify for this discount, drivers need to maintain their driving record clean for a number of years, usually three to five years, depending on each insurance company.
Consider usage-based insurance programs. Some insurers offer usage-based programs. Drivers that enroll in a usage-based program, will have to allow the insurer to install a small telematics device in their vehicles. This device will monitor the policyholder's driving habits. If the monitoring results are good, policyholders are eligible for better policies.
Consider raising deductibles. Policyholders that have full coverage can lower their insurance premium by agreeing to pay a larger deductible.
Check multiple online quotes. This is the best way for drivers to save money. Insurance companies don't offer the same insurance rates, and the best way to find the best insurance is by comparing multiple online quotes.

For additional info, money-saving tips and free car insurance quotes, visit https://compare-autoinsurance.org/

Compare-autoinsurance.org is an online provider of life, home, health, and auto insurance quotes. This website is unique because it does not simply stick to one kind of insurance provider, but brings the clients the best deals from many different online insurance carriers. In this way, clients have access to offers from multiple carriers all in one place: this website. On this site, customers have access to quotes for insurance plans from various agencies, such as local or nationwide agencies, brand names insurance companies, etc.

"Many drivers want to pay less on car insurance. For that, they can follow several smart money-saving tips", said Russell Rabichev, Marketing Director of Internet Marketing Company.

CONTACT:

Company Name: Internet Marketing Company
Person for contact: Gurgu C
Phone Number: (818) 359-3898
Email: cgurgu@internetmarketingcompany.biz
Website: https://compare-autoinsurance.org/

SOURCE: Internet Marketing Company

ReleaseID: 595571

Borussia Dortmund Gives an Outlook on The Results for the 2019/2020 Financial Year

DORTMUND, GERMANY / ACCESSWIRE / June 29, 2020 / The Covid-19 pandemic, with its ongoing restrictions on public life and the associated significant effects on both the global economy and Borussia Dortmund's operating business, has caused and is still causing considerable uncertainty. The company had therefore initially withdrawn its forecast for the entire 2019/2020 financial year from the market and made no new forecast (see our ad hoc announcement of March 16, 2020) and then – without a detailed earnings forecast – announced that the Management assumes that no positive consolidated annual result will be achieved for the entire 2019/2020 financial year (see our ad hoc announcement of May 8, 2020).

With completion of the 34th match day and the resulting termination of the Bundesliga season 2019/2020 – recently by means of special match operations "without spectators" – in the association's specified period of a season end before June 30th, the management of Borussia Dortmund decided today, based on the current findings, to give an outlook on key earnings figures for 2019/2020 financial year.

Borussia Dortmund group now expects an EBITDA of approx. EUR 62 million and a consolidated net loss of approx. EUR 45 million. This outlook is subject to value-adjusting facts until the completion of the preparation of the annual financial statements and the knowledge gained in the course of the audit of the consolidated financial statements for the 2019/2020 financial year after the balance sheet date as well as possible further transfer income.

The expected aforesaid key figures have to be understood as a direct impact of the Covid-19 pandemic, which has affected all Borussia Dortmund income and revenue sources. Borussia Dortmund has the largest stadium in Germany with a total capacity of 81,365 spectators and the second largest VIP hospitality areas. The special match operations "without spectators" therefore had a significant impact (see also our corporate news from March 9, 2020). In addition, reductions and / or refunds of advertising and VIP hospitality proceeds have been made. It is also important that the global transfer market came nearly to a complete standstill in the fourth quarter.

Due to the good earnings situation in the past financial years and in the period of the current financial year up to the start of the Covid-19 pandemic, due to a group equity of approx. EUR 355 million as of 30. June 2019 (corresponding to an equity ratio of approx. 71%) and thanks to the company's sustainable positioning, Borussia Dortmund is prepared to bear the expected losses.

The management continuously evaluates the situation around the ongoing Covid-19 pandemic and is now focusing on the development of new concepts and measures for the start of the new 2020/2021 season.

Dortmund, 29. June 2020

Borussia Dortmund GmbH & Co. KGaA
Borussia Dortmund Geschäftsführungs-GmbH

Contact:
Dr. Robin Steden
Inhouse Counsel / Investor Relations

SOURCE: Borussia Dortmund GmbH & Co. KGaA

ReleaseID: 595584

snapIoT Announces AI-Powered Automated IRB Packaging and UAT Reporting for Patient Engagement Solutions

SAN DIEGO, CA / ACCESSWIRE / June 29, 2020 / snapIoT Inc., a San Diego-based company, announces Automated AI-powered IRB Packaging and UAT Reporting feature to assemble all patient-facing visual assets and expedite the submission process for IRB and ethics approvals. Traditionally, this time-consuming process of IRB and ethics packaging is prone to human error and performed manually at the end of app development stages.

snapClinical™'s AI-powered Automated Documentation Engine creates key patient facing documentation assets for IRB Package setup and submission as well as UAT Reporting. With one single click, an AI-powered automation engine will: execute the app, go through all screens and generate screenshots, traverse all protocol flows and gather forms data information and auto-generate the needed materials within a single report. Annotations can be documented and exported to various file formats for further editing and processing. Pharma and CRO companies now have a faster, more efficient, and reliable method to help launch digitally enabled clinical trials.

"We have worked very closely with an early stage User Group comprised of many of the Top 10 Pharmaceutical and CRO companies as well as several IRB and Ethics SME's to rapidly deploy this modern feature. Our Automated AI-powered IRB Packaging and UAT Reporting feature achieves the objectives of a better streamlined process to reduce time, costs and human error," said Isaac Eteminan, CEO of snapIoT.

About snapIoT

snapIoT, a San Diego-based company, is a market leader in de-centralized mClinical trial innovation. Their mClinical platform, snapClinical™, provides unlimited capabilities in developing and deploying patient-centric engagement solutions such as eConsent, eCOA, Telemedicine, and various other patient engagement solutions to support decentralized trials. snapClinical functions as both a SaaS/PaaS model to allow users to build self-service solutions on Android, iOS, and HTML5 via intuitive drag-and-drop platform, or as a full turnkey service. For more information, visit https://snapiot.com/ and follow snapIoT on LinkedIn.

Sales & Press Inquiries:

Mary Briggs
VP Delivery Excellence
mary@snapiot.com

SOURCE: snapIoT

ReleaseID: 595101

KGJI Investor Alert: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Kingold Jewelry, Inc. and Encourages Investors to Contact the Firm

NEW YORK, NY / ACCESSWIRE / June 29, 2020 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Kingold Jewelry, Inc. ("Kingold" or "the Company") (NASDAQ:KGJI). Investors who purchased Kingold securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: www.bgandg.com/kgji.

The investigation concerns whether Kingold and certain of its officers and/or directors have violated federal securities laws.

If you are aware of any facts relating to this investigation or purchased Kingold shares, you can assist this investigation by visiting the firm's site: www.bgandg.com/kgji. You can also contact Peretz Bronstein or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC: 212-697-6484.

CONTACT:
Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein | Yael Hurwitz

212-697-6484 | info@bgandg.com

SOURCE: Bronstein, Gewirtz and Grossman, LLC

ReleaseID: 595619